News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Rainbow BioSciences, LLC Visits Texas Genome-Mapping Target


1/22/2013 9:30:11 AM

NOKOMIS, Fla.--(BUSINESS WIRE)--Since the new year began, Rainbow Coral Corp. (OTCBB: RBCC) has wasted no time in searching for new targets to add to its portfolio of projects for commercialization. Last week, the Company’s executive leadership accepted an invitation to tour a genome-mapping facility in Houston with which RBCC could soon partner. New healthcare innovations related to the human genome represent a target-rich area of interest for RBCC. The Texas company currently being reviewed performs tests to identify genetic markers in patients that can potentially boost or nullify the effects of certain medications. Such testing could dramatically change the way medications are prescribed, potentially fostering a significant reduction in global health care costs.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES